Oncomatryx

Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment. Its priority is to develop novel precision drugs targeting proteins located in the tumor microenvironment. A new approach to cancer treatment that focuses not on tumor epithelial cells, but on stromal cells that promote their invasiveness, immune suppression, and drug resistance.